Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate

Background Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time i...

Full description

Saved in:
Bibliographic Details
Published inJournal of magnetic resonance imaging Vol. 56; no. 1; pp. 184 - 195
Main Authors Johnson, Patricia M., Tong, Angela, Donthireddy, Awani, Melamud, Kira, Petrocelli, Robert, Smereka, Paul, Qian, Kun, Keerthivasan, Mahesh B., Chandarana, Hersh, Knoll, Florian
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.07.2022
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first‐line screening modality. Purpose To accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction. Study Type Retrospective. Subjects One hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI. Field Strength/Sequence 3.0 T; a T2 turbo spin echo (TSE) T2‐weighted image (T2WI) sequence in axial and coronal planes, and axial echo‐planar diffusion‐weighted imaging (DWI). Assessment Four abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under‐sampled biparametric MRIs (bp‐MRI), and standard bp‐MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm2 and B1000 seconds/mm (4‐fold T2WI, 3‐fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non‐diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp‐MRI—which additionally included calculated B1500 seconds/mm2, and apparent diffusion coefficient map—according to the Prostate Imaging Reporting and Data System (PI‐RADS v2.1), for both VN and standard reconstructions. Accuracy of PI‐RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under‐sampled biparametric exam was also computed. Statistical Tests One‐sided Wilcoxon signed‐rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp‐MRI. A P‐value of <0.05 was considered statistically significant. Results Three of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm2 (Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm2 (Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI‐RADS ≥3 lesions identified on standard vs. VN bp‐MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam. Data Conclusion Diagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI. Level of Evidence 3 Technical Efficacy Stage 5
AbstractList Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate-specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first-line screening modality. To accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction. Retrospective. One hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI. 3.0 T; a T2 turbo spin echo (TSE) T2-weighted image (T2WI) sequence in axial and coronal planes, and axial echo-planar diffusion-weighted imaging (DWI). Four abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under-sampled biparametric MRIs (bp-MRI), and standard bp-MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm and B1000 seconds/mm (4-fold T2WI, 3-fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non-diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp-MRI-which additionally included calculated B1500 seconds/mm , and apparent diffusion coefficient map-according to the Prostate Imaging Reporting and Data System (PI-RADS v2.1), for both VN and standard reconstructions. Accuracy of PI-RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under-sampled biparametric exam was also computed. One-sided Wilcoxon signed-rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp-MRI. A P-value of <0.05 was considered statistically significant. Three of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm (Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm (Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI-RADS ≥3 lesions identified on standard vs. VN bp-MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam. Diagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI. 3 TECHNICAL EFFICACY: Stage 5.
Background Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first‐line screening modality. Purpose To accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction. Study Type Retrospective. Subjects One hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI. Field Strength/Sequence 3.0 T; a T2 turbo spin echo (TSE) T2‐weighted image (T2WI) sequence in axial and coronal planes, and axial echo‐planar diffusion‐weighted imaging (DWI). Assessment Four abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under‐sampled biparametric MRIs (bp‐MRI), and standard bp‐MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm2 and B1000 seconds/mm (4‐fold T2WI, 3‐fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non‐diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp‐MRI—which additionally included calculated B1500 seconds/mm2, and apparent diffusion coefficient map—according to the Prostate Imaging Reporting and Data System (PI‐RADS v2.1), for both VN and standard reconstructions. Accuracy of PI‐RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under‐sampled biparametric exam was also computed. Statistical Tests One‐sided Wilcoxon signed‐rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp‐MRI. A P‐value of <0.05 was considered statistically significant. Results Three of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm2 (Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm2 (Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI‐RADS ≥3 lesions identified on standard vs. VN bp‐MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam. Data Conclusion Diagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI. Level of Evidence 3 Technical Efficacy Stage 5
Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate-specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first-line screening modality.BACKGROUNDEarly diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate-specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first-line screening modality.To accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction.PURPOSETo accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction.Retrospective.STUDY TYPERetrospective.One hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI.SUBJECTSOne hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI.3.0 T; a T2 turbo spin echo (TSE) T2-weighted image (T2WI) sequence in axial and coronal planes, and axial echo-planar diffusion-weighted imaging (DWI).FIELD STRENGTH/SEQUENCE3.0 T; a T2 turbo spin echo (TSE) T2-weighted image (T2WI) sequence in axial and coronal planes, and axial echo-planar diffusion-weighted imaging (DWI).Four abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under-sampled biparametric MRIs (bp-MRI), and standard bp-MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm2 and B1000 seconds/mm (4-fold T2WI, 3-fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non-diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp-MRI-which additionally included calculated B1500 seconds/mm2 , and apparent diffusion coefficient map-according to the Prostate Imaging Reporting and Data System (PI-RADS v2.1), for both VN and standard reconstructions. Accuracy of PI-RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under-sampled biparametric exam was also computed.ASSESSMENTFour abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under-sampled biparametric MRIs (bp-MRI), and standard bp-MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm2 and B1000 seconds/mm (4-fold T2WI, 3-fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non-diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp-MRI-which additionally included calculated B1500 seconds/mm2 , and apparent diffusion coefficient map-according to the Prostate Imaging Reporting and Data System (PI-RADS v2.1), for both VN and standard reconstructions. Accuracy of PI-RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under-sampled biparametric exam was also computed.One-sided Wilcoxon signed-rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp-MRI. A P-value of <0.05 was considered statistically significant.STATISTICAL TESTSOne-sided Wilcoxon signed-rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp-MRI. A P-value of <0.05 was considered statistically significant.Three of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm2 (Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm2 (Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI-RADS ≥3 lesions identified on standard vs. VN bp-MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam.RESULTSThree of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm2 (Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm2 (Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI-RADS ≥3 lesions identified on standard vs. VN bp-MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam.Diagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI.DATA CONCLUSIONDiagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI.3 TECHNICAL EFFICACY: Stage 5.LEVEL OF EVIDENCE3 TECHNICAL EFFICACY: Stage 5.
BackgroundEarly diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first‐line screening modality.PurposeTo accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction.Study TypeRetrospective.SubjectsOne hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI.Field Strength/Sequence3.0 T; a T2 turbo spin echo (TSE) T2‐weighted image (T2WI) sequence in axial and coronal planes, and axial echo‐planar diffusion‐weighted imaging (DWI).AssessmentFour abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under‐sampled biparametric MRIs (bp‐MRI), and standard bp‐MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm2 and B1000 seconds/mm (4‐fold T2WI, 3‐fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non‐diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp‐MRI—which additionally included calculated B1500 seconds/mm2, and apparent diffusion coefficient map—according to the Prostate Imaging Reporting and Data System (PI‐RADS v2.1), for both VN and standard reconstructions. Accuracy of PI‐RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under‐sampled biparametric exam was also computed.Statistical TestsOne‐sided Wilcoxon signed‐rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp‐MRI. A P‐value of <0.05 was considered statistically significant.ResultsThree of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm2 (Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm2 (Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI‐RADS ≥3 lesions identified on standard vs. VN bp‐MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam.Data ConclusionDiagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI.Level of Evidence3Technical EfficacyStage 5
Author Petrocelli, Robert
Knoll, Florian
Qian, Kun
Johnson, Patricia M.
Smereka, Paul
Keerthivasan, Mahesh B.
Melamud, Kira
Tong, Angela
Chandarana, Hersh
Donthireddy, Awani
AuthorAffiliation 1 Center for Advanced Imaging Innovation and Research (CAI2R), Department of Radiology, New York University School of Medicine, New York, NY, USA
2 Division of Biostatistics, Department of Population Health, New York University School of Medicine, New York, NY, USA
3 Siemens Medical Solutions USA Inc, Malvern, PA, United States
AuthorAffiliation_xml – name: 3 Siemens Medical Solutions USA Inc, Malvern, PA, United States
– name: 2 Division of Biostatistics, Department of Population Health, New York University School of Medicine, New York, NY, USA
– name: 1 Center for Advanced Imaging Innovation and Research (CAI2R), Department of Radiology, New York University School of Medicine, New York, NY, USA
Author_xml – sequence: 1
  givenname: Patricia M.
  orcidid: 0000-0003-1547-9969
  surname: Johnson
  fullname: Johnson, Patricia M.
  email: patricia.johnson3@nyulangone.org
  organization: New York University School of Medicine
– sequence: 2
  givenname: Angela
  surname: Tong
  fullname: Tong, Angela
  organization: New York University School of Medicine
– sequence: 3
  givenname: Awani
  surname: Donthireddy
  fullname: Donthireddy, Awani
  organization: New York University School of Medicine
– sequence: 4
  givenname: Kira
  surname: Melamud
  fullname: Melamud, Kira
  organization: New York University School of Medicine
– sequence: 5
  givenname: Robert
  surname: Petrocelli
  fullname: Petrocelli, Robert
  organization: New York University School of Medicine
– sequence: 6
  givenname: Paul
  surname: Smereka
  fullname: Smereka, Paul
  organization: New York University School of Medicine
– sequence: 7
  givenname: Kun
  surname: Qian
  fullname: Qian, Kun
  organization: New York University School of Medicine
– sequence: 8
  givenname: Mahesh B.
  surname: Keerthivasan
  fullname: Keerthivasan, Mahesh B.
  organization: Siemens Medical Solutions USA Inc
– sequence: 9
  givenname: Hersh
  surname: Chandarana
  fullname: Chandarana, Hersh
  organization: New York University School of Medicine
– sequence: 10
  givenname: Florian
  surname: Knoll
  fullname: Knoll, Florian
  organization: New York University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34877735$$D View this record in MEDLINE/PubMed
BookMark eNp9kV9rFDEUxYO02Hb1xQ8gAV-kMDV_JjOTF6G21W7Zoiz6HLKZm90sM8k2mVH225t121KL-JQL-d3DPeecoAMfPCD0hpIzSgj7sO6jO2MNYeULdEwFYwUTTXWQZyJ4QRtSH6GTlNaEEClL8RId8bKp65qLY6QuATZ4Bjp655d4Dib4NMTRDC54fOX1ooOEr91y1W3xuTHQQdQDtPiT2-ioexiiM_h2jqe9Xu4UgsXDCvC3GNKQwVfo0Oouwev7d4J-fL76fnFdzL5-mV6czwojaFkWDYFaUEutNYYSaqHiFFohoTKSt60WsuZtVXPKpZF2wbkQlmhZaRBAaGYm6ONedzMuemgN-CHqTm2i63XcqqCd-vvHu5Vahp9K0po0fCfw_l4ghrsR0qB6l7LdTnsIY1KsIg1lTJZlRt89Q9dhjD7by1S2IUiZT52gt08vejzlIfsMnO4Bk7NKEewjQonaFat2xao_xWaYPIONy_nmkrIb1_17he5XfrkOtv8RVze38-l-5zcgE7Yu
CitedBy_id crossref_primary_10_1097_RLI_0000000000001110
crossref_primary_10_1016_j_ejrad_2023_110757
crossref_primary_10_1097_RLI_0000000000001171
crossref_primary_10_1002_mrm_30105
crossref_primary_10_1002_jmri_28602
crossref_primary_10_1002_jmri_28603
crossref_primary_10_1038_s41598_024_79348_5
crossref_primary_10_1016_j_acra_2024_06_048
crossref_primary_10_1016_j_rcl_2023_06_006
crossref_primary_10_1016_j_ejrad_2023_111017
crossref_primary_10_1016_j_ejrad_2023_110887
crossref_primary_10_1016_j_ejrad_2025_111997
crossref_primary_10_1007_s11547_024_01861_4
crossref_primary_10_1093_dmfr_twae063
crossref_primary_10_2214_AJR_24_32588
crossref_primary_10_1038_s41598_025_94777_6
crossref_primary_10_1007_s00330_024_10776_7
crossref_primary_10_1007_s00261_024_04396_4
crossref_primary_10_1097_RLI_0000000000000997
crossref_primary_10_1177_02841851231192786
crossref_primary_10_1177_02841851241273114
crossref_primary_10_3390_cancers15030578
crossref_primary_10_1007_s00256_023_04321_8
crossref_primary_10_1016_j_acra_2023_05_010
crossref_primary_10_1148_radiol_230427
crossref_primary_10_1002_jmri_29269
crossref_primary_10_1259_bjr_20211378
crossref_primary_10_6009_jjrt_2023_2260
crossref_primary_10_1002_jmri_28577
crossref_primary_10_1002_mrm_29485
crossref_primary_10_1016_j_ejro_2024_100588
crossref_primary_10_1038_s41597_024_03252_w
crossref_primary_10_1016_j_ejro_2025_100635
crossref_primary_10_1093_bjr_tqae093
crossref_primary_10_1109_ACCESS_2023_3344456
crossref_primary_10_1148_radiol_220425
crossref_primary_10_1002_jmri_29025
crossref_primary_10_1148_radiol_241009
crossref_primary_10_1016_j_acra_2023_06_035
crossref_primary_10_1016_j_ejrad_2023_110953
crossref_primary_10_3390_cancers14235741
crossref_primary_10_1148_radiol_233337
crossref_primary_10_1186_s13244_024_01686_9
crossref_primary_10_1007_s00330_023_09781_z
Cites_doi 10.1148/radiol.2017170129
10.14740/wjon1191
10.1002/mrm.26977
10.1117/1.JMI.5.4.044507
10.1002/mrm.21391
10.1016/j.juro.2015.10.140
10.1109/TMI.2018.2865356
10.1148/radiol.2018180445
10.1002/jmri.23689
10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S
10.1109/TBME.2018.2821699
10.1016/j.ejrad.2021.109600
10.2214/AJR.11.8446
10.1001/jama.2018.3712
10.1007/978-3-030-59713-9_7
10.1016/j.euo.2018.03.008
10.1002/mrm.10171
10.1001/jamaoncol.2020.7456
10.2214/AJR.20.23313
10.1016/j.eururo.2018.11.031
10.1038/s41598-019-55972-4
10.1007/978-3-319-24574-4_28
10.1109/TIP.2003.819861
10.1097/JU.0000000000000713
10.1016/S0140-6736(16)32401-1
10.1007/s11934-015-0507-9
10.3310/hta22390
10.1016/j.ejca.2011.06.055
10.1111/j.1464-410X.2012.11611.x
10.1002/mrm.24751
10.1001/jama.1994.03510290050036
10.1016/j.eururo.2019.05.029
10.1056/NEJMoa1801993
10.1001/jama.2014.17942
ContentType Journal Article
Copyright 2021 International Society for Magnetic Resonance in Medicine.
2022 International Society for Magnetic Resonance in Medicine
Copyright_xml – notice: 2021 International Society for Magnetic Resonance in Medicine.
– notice: 2022 International Society for Magnetic Resonance in Medicine
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7TK
8FD
FR3
K9.
P64
7X8
5PM
DOI 10.1002/jmri.28024
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-2586
EndPage 195
ExternalDocumentID PMC9170839
34877735
10_1002_jmri_28024
JMRI28024
Genre article
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: National Institutes of Health
  funderid: R01 EB024532
– fundername: National Cancer Institute
  funderid: R21 CA256324‐01; P41EB017183
– fundername: NIBIB NIH HHS
  grantid: R01 EB024532
– fundername: NIBIB NIH HHS
  grantid: P41 EB017183
– fundername: NCI NIH HHS
  grantid: R21 CA256324-01
– fundername: NCI NIH HHS
  grantid: P41EB017183
– fundername: NCI NIH HHS
  grantid: R21 CA256324
GroupedDBID ---
-DZ
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HDBZQ
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V8K
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7TK
8FD
FR3
K9.
P64
7X8
5PM
ID FETCH-LOGICAL-c5144-80e751f1ffcc101fe631ed59e6c93dda5973d673139c9fb3355f0a96ae5e01c93
IEDL.DBID DR2
ISSN 1053-1807
1522-2586
IngestDate Thu Aug 21 18:37:48 EDT 2025
Fri Jul 11 03:35:54 EDT 2025
Fri Jul 25 12:11:05 EDT 2025
Mon Jul 21 05:26:26 EDT 2025
Thu Apr 24 22:57:21 EDT 2025
Tue Jul 01 03:56:52 EDT 2025
Wed Jan 22 16:23:57 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords deep learning
prostate MRI
image reconstruction
accelerated imaging
Language English
License 2021 International Society for Magnetic Resonance in Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5144-80e751f1ffcc101fe631ed59e6c93dda5973d673139c9fb3355f0a96ae5e01c93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-1547-9969
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/9170839
PMID 34877735
PQID 2675150467
PQPubID 1006400
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9170839
proquest_miscellaneous_2608122944
proquest_journals_2675150467
pubmed_primary_34877735
crossref_primary_10_1002_jmri_28024
crossref_citationtrail_10_1002_jmri_28024
wiley_primary_10_1002_jmri_28024_JMRI28024
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2022
PublicationDateYYYYMMDD 2022-07-01
PublicationDate_xml – month: 07
  year: 2022
  text: July 2022
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Nashville
PublicationSubtitle JMRI
PublicationTitle Journal of magnetic resonance imaging
PublicationTitleAlternate J Magn Reson Imaging
PublicationYear 2022
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2021; 7
2019; 9
2015; 16
2019; 75
2019; 10
2019; 76
2018; 289
1994; 271
2019; 38
2020; 203
1999; 42
2018; 22
2018; 65
2007; 58
2015; 9351
2002; 47
2013; 37
2012; 199
2018; 5
2015; 313
2018; 1
2021; 137
2020
2018; 378
2004; 13
2020; 215
2020; 28
2013; 111
2018; 319
2017; 285
2014
2011; 47
2017; 389
2014; 71
2016; 195
2018; 79
e_1_2_6_32_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_30_1
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_36_1
e_1_2_6_14_1
e_1_2_6_35_1
e_1_2_6_11_1
e_1_2_6_34_1
e_1_2_6_12_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
e_1_2_6_37_1
e_1_2_6_21_1
e_1_2_6_20_1
O'shea A (e_1_2_6_33_1) 2020; 28
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_29_1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
References_xml – volume: 58
  start-page: 1182
  issue: 6
  year: 2007
  end-page: 1195
  article-title: Sparse MRI: The application of compressed sensing for rapid MR imaging
  publication-title: Magn Reson Med
– volume: 271
  start-page: 368
  issue: 5
  year: 1994
  end-page: 374
  article-title: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
  publication-title: JAMA
– volume: 28
  issue: 2450
  year: 2020
  article-title: Initial experience in abbreviated T2‐weighted prostate MRI using a deep learning reconstruction
  publication-title: Proc Intl Soc Mag Reson Med
– volume: 195
  start-page: 1428
  issue: 5
  year: 2016
  end-page: 1435
  article-title: The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer
  publication-title: J Urol
– volume: 22
  start-page: 1
  issue: 39
  year: 2018
  end-page: 176
  article-title: Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound‐guided prostate biopsy alone: The PROMIS study
  publication-title: Health Technol Assess
– volume: 37
  start-page: 48
  issue: 1
  year: 2013
  end-page: 58
  article-title: Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: Could standardization lead to improved utilization of imaging within the diagnostic pathway?
  publication-title: J Magn Reson Imaging
– volume: 10
  start-page: 63
  issue: 2
  year: 2019
  end-page: 89
  article-title: Epidemiology of prostate cancer
  publication-title: World J Oncol
– volume: 203
  start-page: 1122
  issue: 6
  year: 2020
  end-page: 1127
  article-title: Long‐term outcomes of active surveillance for prostate cancer: The Memorial Sloan Kettering Cancer Center experience
  publication-title: J Urol
– volume: 7
  start-page: 395
  issue: 3
  year: 2021
  article-title: Population‐based prostate cancer screening with magnetic resonance imaging or ultrasonography: The IP1‐PROSTAGRAM study
  publication-title: JAMA Oncol
– volume: 13
  start-page: 600
  issue: 4
  year: 2004
  end-page: 612
  article-title: Image quality assessment: From error visibility to structural similarity
  publication-title: IEEE Trans Image Process
– volume: 42
  start-page: 952
  issue: 5
  year: 1999
  end-page: 962
  article-title: SENSE: sensitivity encoding for fast MRI
  publication-title: Magn Reson Med
– volume: 47
  start-page: 1202
  issue: 6
  year: 2002
  end-page: 1210
  article-title: Generalized autocalibrating partially parallel acquisitions (GRAPPA)
  publication-title: Magn Reson Med
– volume: 215
  start-page: 1421
  year: 2020
  end-page: 1429
  article-title: Using deep learning to accelerate knee MRI at 3 T: Results of an interchangeability study
  publication-title: AJR Am J Roentgenol
– volume: 111
  start-page: 753
  issue: 5
  year: 2013
  end-page: 760
  article-title: Prognostic Gleason grade grouping: Data based on the modified Gleason scoring system
  publication-title: BJU Int
– volume: 1
  start-page: 208
  issue: 3
  year: 2018
  end-page: 214
  article-title: Clinical utility of multiparametric magnetic resonance imaging as the first‐line tool for men with high clinical suspicion of prostate cancer
  publication-title: Eur Urol Oncol
– volume: 65
  start-page: 1985
  issue: 9
  year: 2018
  end-page: 1995
  article-title: Deep residual learning for accelerated MRI using magnitude and phase networks
  publication-title: IEEE Trans Biomed Eng
– year: 2014
– volume: 285
  start-page: 493
  issue: 2
  year: 2017
  end-page: 505
  article-title: Abbreviated biparametric prostate MR imaging in men with elevated prostate‐specific antigen
  publication-title: Radiology
– volume: 47
  start-page: 2698
  issue: 18
  year: 2011
  end-page: 2705
  article-title: False‐positive screening results in the European randomized study of screening for prostate cancer
  publication-title: Eur J Cancer
– volume: 313
  start-page: 390
  issue: 4
  year: 2015
  end-page: 397
  article-title: Comparison of MR/ultrasound fusion‐guided biopsy with ultrasound‐guided biopsy for the diagnosis of prostate cancer
  publication-title: JAMA
– volume: 16
  start-page: 42
  issue: 6
  year: 2015
  article-title: The role of MRI in active surveillance for prostate cancer
  publication-title: Curr Urol Rep
– volume: 389
  start-page: 815
  issue: 10071
  year: 2017
  end-page: 822
  article-title: Diagnostic accuracy of multi‐parametric MRI and TRUS biopsy in prostate cancer (PROMIS): A paired validating confirmatory study
  publication-title: Lancet
– volume: 38
  start-page: 394
  issue: 2
  year: 2019
  end-page: 405
  article-title: MoDL: Model‐based deep learning architecture for inverse problems
  publication-title: IEEE Trans Med Imaging
– volume: 9
  start-page: 19518
  issue: 1
  year: 2019
  article-title: Prostate cancer detection using deep convolutional neural networks
  publication-title: Sci Rep
– volume: 79
  start-page: 3055
  issue: 6
  year: 2018
  end-page: 3071
  article-title: Learning a variational network for reconstruction of accelerated MRI data
  publication-title: Magn Reson Med
– volume: 289
  start-page: 366
  issue: 2
  year: 2018
  end-page: 373
  article-title: Variable‐density single‐shot fast spin‐echo MRI with deep learning reconstruction by using variational networks
  publication-title: Radiology
– volume: 76
  start-page: 574
  issue: 5
  year: 2019
  end-page: 581
  article-title: High diagnostic performance of short magnetic resonance imaging protocols for prostate cancer detection in biopsy‐naïve men: The next step in magnetic resonance imaging accessibility
  publication-title: Eur Urol
– year: 2020
– volume: 137
  year: 2021
  article-title: Deep learning‐accelerated T2‐weighted imaging of the prostate: Reduction of acquisition time and improvement of image quality
  publication-title: Eur J Radiol
– volume: 5
  issue: 4
  year: 2018
  article-title: Prostate cancer detection from multi‐institution multiparametric MRIs using deep convolutional neural networks
  publication-title: J Med Imaging
– volume: 319
  start-page: 1914
  issue: 18
  year: 2018
  article-title: Prostate‐specific antigen‐based screening for prostate cancer: Evidence report and systematic review for the US Preventive Services Task Force
  publication-title: JAMA
– volume: 378
  start-page: 1767
  issue: 19
  year: 2018
  end-page: 1777
  article-title: MRI‐targeted or standard biopsy for prostate‐cancer diagnosis
  publication-title: N Engl J Med
– volume: 75
  start-page: 712
  issue: 5
  year: 2019
  end-page: 720
  article-title: Detection of individual prostate cancer foci via multiparametric magnetic resonance imaging
  publication-title: Eur Urol
– volume: 71
  start-page: 990
  issue: 3
  year: 2014
  end-page: 1001
  article-title: ESPIRiT—An eigenvalue approach to autocalibrating parallel MRI: Where SENSE meets GRAPPA
  publication-title: Magn Reson Med
– volume: 199
  start-page: 830
  issue: 4
  year: 2012
  end-page: 837
  article-title: Prostate cancer: Multiparametric MRI for index lesion localization—A multiple‐reader study
  publication-title: AJR Am J Roentgenol
– volume: 9351
  year: 2015
– ident: e_1_2_6_14_1
  doi: 10.1148/radiol.2017170129
– ident: e_1_2_6_2_1
  doi: 10.14740/wjon1191
– ident: e_1_2_6_23_1
  doi: 10.1002/mrm.26977
– ident: e_1_2_6_36_1
  doi: 10.1117/1.JMI.5.4.044507
– ident: e_1_2_6_19_1
  doi: 10.1002/mrm.21391
– ident: e_1_2_6_10_1
  doi: 10.1016/j.juro.2015.10.140
– ident: e_1_2_6_20_1
  doi: 10.1109/TMI.2018.2865356
– ident: e_1_2_6_25_1
  doi: 10.1148/radiol.2018180445
– ident: e_1_2_6_30_1
  doi: 10.1002/jmri.23689
– ident: e_1_2_6_18_1
  doi: 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S
– ident: e_1_2_6_22_1
  doi: 10.1109/TBME.2018.2821699
– ident: e_1_2_6_32_1
  doi: 10.1016/j.ejrad.2021.109600
– ident: e_1_2_6_8_1
  doi: 10.2214/AJR.11.8446
– ident: e_1_2_6_3_1
  doi: 10.1001/jama.2018.3712
– ident: e_1_2_6_21_1
  doi: 10.1007/978-3-030-59713-9_7
– ident: e_1_2_6_11_1
  doi: 10.1016/j.euo.2018.03.008
– ident: e_1_2_6_17_1
  doi: 10.1002/mrm.10171
– ident: e_1_2_6_16_1
  doi: 10.1001/jamaoncol.2020.7456
– ident: e_1_2_6_24_1
  doi: 10.2214/AJR.20.23313
– ident: e_1_2_6_9_1
  doi: 10.1016/j.eururo.2018.11.031
– ident: e_1_2_6_37_1
  doi: 10.1038/s41598-019-55972-4
– ident: e_1_2_6_29_1
  doi: 10.1007/978-3-319-24574-4_28
– ident: e_1_2_6_27_1
– ident: e_1_2_6_28_1
  doi: 10.1109/TIP.2003.819861
– ident: e_1_2_6_35_1
  doi: 10.1097/JU.0000000000000713
– ident: e_1_2_6_7_1
  doi: 10.1016/S0140-6736(16)32401-1
– ident: e_1_2_6_34_1
  doi: 10.1007/s11934-015-0507-9
– ident: e_1_2_6_12_1
  doi: 10.3310/hta22390
– ident: e_1_2_6_4_1
  doi: 10.1016/j.ejca.2011.06.055
– volume: 28
  issue: 2450
  year: 2020
  ident: e_1_2_6_33_1
  article-title: Initial experience in abbreviated T2‐weighted prostate MRI using a deep learning reconstruction
  publication-title: Proc Intl Soc Mag Reson Med
– ident: e_1_2_6_31_1
  doi: 10.1111/j.1464-410X.2012.11611.x
– ident: e_1_2_6_26_1
  doi: 10.1002/mrm.24751
– ident: e_1_2_6_5_1
  doi: 10.1001/jama.1994.03510290050036
– ident: e_1_2_6_15_1
  doi: 10.1016/j.eururo.2019.05.029
– ident: e_1_2_6_6_1
  doi: 10.1056/NEJMoa1801993
– ident: e_1_2_6_13_1
  doi: 10.1001/jama.2014.17942
SSID ssj0009945
Score 2.5594566
Snippet Background Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for...
Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate-specific antigen is a suboptimal screening test for clinically...
BackgroundEarly diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 184
SubjectTerms accelerated imaging
Antigens
Cancer
Computation
Deep Learning
Diagnosis
Diagnostic systems
Diffusion coefficient
Diffusion Magnetic Resonance Imaging - methods
Evaluation
Field strength
Humans
Image processing
Image quality
Image reconstruction
Lesions
Magnetic resonance imaging
Magnetic Resonance Imaging - methods
Male
Mathematical analysis
Medical imaging
Prostate
Prostate - diagnostic imaging
Prostate - pathology
Prostate cancer
prostate MRI
Prostatic Neoplasms - diagnostic imaging
Prostatic Neoplasms - pathology
Rank tests
Retrospective Studies
Screening
Sensitivity
Statistical analysis
Statistical tests
Title Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.28024
https://www.ncbi.nlm.nih.gov/pubmed/34877735
https://www.proquest.com/docview/2675150467
https://www.proquest.com/docview/2608122944
https://pubmed.ncbi.nlm.nih.gov/PMC9170839
Volume 56
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED8hHqa9bGxjWwdMnuCFSSmNnTi1xEu3gQCpCFUg8TJFjj-grE3RCg_jr-fOSdMV0KTxFsmXD9t3vt_F598BbAnlRaYKHkmv0ijRUkZFYtNIC2EziRrjAtlz_1genCVH5-n5EuzOzsJU_BDNDzeyjLBek4HrYrozJw29Gv8etnkXfQwuwJSsRYhoMOeOUipUKEb8IKK428kablK-M7910Rs9gpiPMyX_RrDBBe2_hp-zj68yT361b2-Ktrl7wOv43N6twKsam7JepUxvYMmVb-FFv959fwf5D-euWc3IesEocp3zz7K9cApryihzZPSH9YxBj0ZEFJZ9GxLD-JiKdxnWH7DDcaiNxCaeIf5kJ3TyBAVX4Wx_7_T7QVQXaIgM4qwEvZvL0tjH3huDpu2dFLGzqXLSKGGtxmBFWJkJRJlG-UIgtvEdraR2qevEKPMelstJ6T4Cow1P7j2Gc9YlsZVaJ3HsEbtJRDCiUC3Ynk1Ubmr2ciqiMcor3mWe04jlYcRasNnIXlecHU9Krc_mO6_tdppzjJ8QIqP3aMGXphktjrZRdOkmtySDMIpzleAjPlTq0bxGJMSvKNIWZAuK0wgQm_diSzm8DKzeGDcjHMaOfg168Y8vz4_6g8Nw9el_hNfgJaezGyHXeB2WUT_cBiKqm-JzsJx7k48dGw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3fT9swEMdPDKRtLzD2s4NtnraXTUpp7MTBj2yAWkbQVIHEm5X4x9aNpojCw_jruXNCSgFN2t4q5do0zl3ue7H9OYCPQnmRqZJH0qs0SgopozKxaVQIYTOJHuMC7Dk_kP2jZO84PW7W5tBemJoP0b5wo8gIz2sKcHohvTGjhv4an426fBOTzANYopbehM7fHs7oUUqFHsWoIEQUb_aylk7KN2bfnc9Hd0Tm3bWSNzVsSEK7K3Wn1WlgF9Lak9_di_Oyay5vkR3_-_qewHIjT9lW7U-rsOCqp_Awbybgn4Hedu6UNVDWH4yK1xmClu2EjVhTRotHTv6wLWMwqRGLwrIvI4KMj6l_l2H5kA3GoT0Sm3iGEpR9p80naPgcjnZ3Dr_2o6ZHQ2RwwBNMcC5LYx97bwxGt3dSxM6mykmjhLUF1ivCykyg0DTKlwLlje8VShYudb0YbV7AYjWp3CtgNOfJvceKzroktrIokjj2KN8kihhRqg58ur5T2jQAc-qjcaJr9DLXNGI6jFgHPrS2pzW2416r9esbrpvQnWqOJRSqZEwgHXjfHsago5mUonKTC7JBJcW5SvAnXtb-0Z5GJIRYFGkHsjnPaQ0I6D1_pBr9DGBvLJ1REeOFfg6O8Zd_rvfy4SB8ev0vxu_gUf8w39f7g4Nva_CY01aOsPR4HRbRV9wbFFjn5dsQRldKDCE3
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VIlVceD8CBRbBBSSn8e563ZW4FNKoKaSqIir1glb2PmhK40S0PcCvZ2btOIQiJLhZ2rG9jxnPN96dbwBeCR1ErkueqKCzRBZKJaV0WVII4XKFGuMj2fPoQO0dyf3j7HgN3i5yYWp-iPaHG1lG_F6Tgc9d2FqShp5Ov026fBt9zDW4LlVPU-GG_nhJHqV1LFGMAEIk6XYvb8lJ-dby3lV3dAVjXj0q-SuEjT5ocAs-L3pfHz352r28KLv2x2_Ejv87vNtwswGnbKfWpjuw5qu7sDFqtt_vgel7P2cNJesXRqHrkoCW7cY0rHNGR0fOvrMda9GlEROFY-8mRDE-pepdlo3GbDiNxZHYLDAEoOyQUk9Q8D4cDXY_vd9LmgoNiUWgJdG9-TxLQxqCtWjbwSuRepdpr6wWzhUYrQincoEw0-pQCgQ3oVdoVfjM91KUeQDr1azyj4DRjicPAeM552XqVFHINA0I3hRCGFHqDrxeLJSxDX05VdE4MzXxMjc0YybOWAdetrLzmrTjj1Kbi_U2jeGeG44BFGJkdB8deNE2o8nRPkpR-dklySCO4lxLfMTDWj3a1whJBIsi60C-ojitANF5r7ZUk5NI642BM-JhHOibqBd_6bnZH42H8erxvwg_h43D_sB8HB58eAI3OOVxxHPHm7COquKfIrq6KJ9FI_oJ1QEf5g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Deep+Learning+Reconstruction+Enables+Highly+Accelerated+Biparametric+MR+Imaging+of+the+Prostate&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Johnson%2C+Patricia+M&rft.au=Tong%2C+Angela&rft.au=Donthireddy%2C+Awani&rft.au=Melamud%2C+Kira&rft.date=2022-07-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1053-1807&rft.eissn=1522-2586&rft.volume=56&rft.issue=1&rft.spage=184&rft.epage=195&rft_id=info:doi/10.1002%2Fjmri.28024&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon